LDHA and Hepatic fibrosis: Here, we observed that oroxylin A suppressed the expression and activity of LDH-A in HSCs, and, using chemical and genetic approaches, confirmed that inhibition of LDH-A was a prerequisite for oroxylin A reduction of glycolysis-dependent HSC contraction and liver fibrosis in vitro and in vivo.